JAMA Neurol:右旋安非他明联合理疗不能改善脑卒中患者的运动功能

2018-08-28 zhangfan MedSci原创

研究认为,右旋安非他明联合理疗不能改善脑卒中患者的运动功能

模型研究显示,右旋安非他明联合适当的任务训练有助于改善局灶性脑损伤动物预后。近日研究人员考察了上述方案对脑卒中后患者运动功能恢复的影响。

64名皮层或皮质下缺血性脑卒中后中、重度运动障碍患者参与研究,随机接受10mg右旋安非他明或安慰剂(各组32人),在服用后1小时后接受为期1小时的理疗。研究的主要终点为中风后3个月Fugl-Meyer运动能力评估变化,次要终点包括国家卫生研究院卒中评估、加拿大神经学评估、手臂动作能力测验、改良Rankin评估、功能独立评估、行走速度和距离、简易精神状态检查、Beck抑郁评估和中风影响评估。

参与者平均年龄66岁,男性占55%,在中风后10-30天参与研究。3个月后,组间Fugl-Meyer得分改善差异不显著(安非他明组得分减少18.65分,对照组减少20.83分)。各个次要终点、根据中风位置及严重程度的亚组分析差异也不显著。未发生治疗相关的严重不良事件。

研究认为,右旋安非他明联合理疗不能改善脑卒中患者的运动功能。


原始出处:


本文系williamhill asia 医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1696536, encodeId=d4c91696536d2, content=<a href='/topic/show?id=2c5194149af' target=_blank style='color:#2F92EE;'>#运动功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94149, encryptionId=2c5194149af, topicName=运动功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9629890329, createdName=doctor-chen9592, createdTime=Wed Dec 05 06:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720253, encodeId=0af01e2025321, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 12 01:03:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679120, encodeId=782816e9120ec, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sat Nov 03 21:03:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000558, encodeId=dcb0200055863, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 03 14:03:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026138, encodeId=f24a102613809, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Aug 28 13:03:00 CST 2018, time=2018-08-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1696536, encodeId=d4c91696536d2, content=<a href='/topic/show?id=2c5194149af' target=_blank style='color:#2F92EE;'>#运动功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94149, encryptionId=2c5194149af, topicName=运动功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9629890329, createdName=doctor-chen9592, createdTime=Wed Dec 05 06:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720253, encodeId=0af01e2025321, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 12 01:03:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679120, encodeId=782816e9120ec, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sat Nov 03 21:03:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000558, encodeId=dcb0200055863, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 03 14:03:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026138, encodeId=f24a102613809, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Aug 28 13:03:00 CST 2018, time=2018-08-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1696536, encodeId=d4c91696536d2, content=<a href='/topic/show?id=2c5194149af' target=_blank style='color:#2F92EE;'>#运动功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94149, encryptionId=2c5194149af, topicName=运动功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9629890329, createdName=doctor-chen9592, createdTime=Wed Dec 05 06:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720253, encodeId=0af01e2025321, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 12 01:03:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679120, encodeId=782816e9120ec, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sat Nov 03 21:03:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000558, encodeId=dcb0200055863, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 03 14:03:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026138, encodeId=f24a102613809, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Aug 28 13:03:00 CST 2018, time=2018-08-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1696536, encodeId=d4c91696536d2, content=<a href='/topic/show?id=2c5194149af' target=_blank style='color:#2F92EE;'>#运动功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94149, encryptionId=2c5194149af, topicName=运动功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9629890329, createdName=doctor-chen9592, createdTime=Wed Dec 05 06:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720253, encodeId=0af01e2025321, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 12 01:03:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679120, encodeId=782816e9120ec, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sat Nov 03 21:03:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000558, encodeId=dcb0200055863, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 03 14:03:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026138, encodeId=f24a102613809, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Aug 28 13:03:00 CST 2018, time=2018-08-28, status=1, ipAttribution=)]
    2018-12-03 yinhl1978
  5. [GetPortalCommentsPageByObjectIdResponse(id=1696536, encodeId=d4c91696536d2, content=<a href='/topic/show?id=2c5194149af' target=_blank style='color:#2F92EE;'>#运动功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94149, encryptionId=2c5194149af, topicName=运动功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce9629890329, createdName=doctor-chen9592, createdTime=Wed Dec 05 06:03:00 CST 2018, time=2018-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1720253, encodeId=0af01e2025321, content=<a href='/topic/show?id=915c3604e6b' target=_blank style='color:#2F92EE;'>#卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36047, encryptionId=915c3604e6b, topicName=卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=940232842333, createdName=wangyang7969, createdTime=Tue Feb 12 01:03:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679120, encodeId=782816e9120ec, content=<a href='/topic/show?id=7a2684e600b' target=_blank style='color:#2F92EE;'>#脑卒中患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84760, encryptionId=7a2684e600b, topicName=脑卒中患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=091e27733095, createdName=weihongyv, createdTime=Sat Nov 03 21:03:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2000558, encodeId=dcb0200055863, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Dec 03 14:03:00 CST 2018, time=2018-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026138, encodeId=f24a102613809, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Aug 28 13:03:00 CST 2018, time=2018-08-28, status=1, ipAttribution=)]
    2018-08-28 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

相关威廉亚洲官网

Neurology:脑卒中后失语与白质疏松独立相关

研发认为中风患者白质疏松是语言功能预后的重要预测因素,失语症与非梗死脑组织的完整性密切相关

Stroke:急性脑卒中后血压波动越大 结局越糟糕!

2018年7月,发表于《Stroke》上的一项研究,表明了脑出血后血压变异性(BPV)的增加会加剧更差的结局。

Radiology:皮层下脑卒中连接破坏所致注意力缺失

本研究旨在通过结合基于体素病变-症状图谱和扩散张量(DT)纤维追踪技术评价慢性皮层下脑卒中所致神经基质相关的注意力缺失,并将结果发表在Radiology上。

预防脑卒中,有效管理血压是关键

脑血管疾病主要包括缺血性卒中和出血性卒中(合称脑卒中),在我国是致残和死亡的首要原因。脑卒中发病风险中的90%可以归咎为已知的10个危险因素的作用,其中高血压是首位危险因素。因此,本期williamhill asia 将介绍如何管理脑卒中及其高危风险人群的高血压问题。

天津建成9家**脑卒中中心

卒中中心建设是天津市2018年20项民心工程之一。该工程提出,力争到今年年底建成8家国家级脑卒中中心,将患者到达医院至开始静脉溶栓治疗的平均时间缩短至60分钟内。截至目前,天津市已建成9家国家级脑卒中中心,该项民心工程建设任务已经提前超额完成。

Stroke:轻型脑卒中 哪些情况需开始静脉溶栓治疗?

2018年7月,发表于《Stroke》上的一项研究,考察了静脉溶栓治疗轻型脑卒中的影响因素。